Skip to main content
. 2020 Jul 20;10(7):465. doi: 10.3390/brainsci10070465
SARS-COV-2 Severe acute respiratory syndrome coronavirus 2
COVID-19 Coronavirus Disease 2019
ICU Intensive Care Unit
ECMO extracorporeal membrane oxygenation
NSAIDs Nonsteroidal anti-inflammatory drugs
CPOT Critical Care Pain Observation Tool
BPS Behavioral Pain Scale
WHO World Health Organization
RNA ribonucleic acid
SARS Severe Acute Respiratory Syndrome
MERS Middle East Respiratory Syndrome
et al. et alia
PNS peripheral nervous system
CNS Central nervous system
IL Interleukin
ACE2 Angiotensin-converting enzyme 2
ANG Angiotensin
TNF tumor necrosis factor
PGE2 Prostaglandin E2
CSF Cerebrospinal Fluid
TG Trigeminal ganglia
CGRP calcitonin gene-related peptide
VAS visual analogue scale
NRS numerical assessment scale
NMB neuromuscular blocking medications
CoVs Coronaviruses
COPD chronic obstructive pulmonary disease
NK Natural Killer cells
RR Relative risk
COX cyclooxygenase
LOX lipoxygenase
EMA European Medicines Agency
OCT Over-the-counter drug
ASA acetylsalicylic acid
NNT numbers needed to treat